O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up

Gespeichert in:

Autor*in:	Ceulemans, B [verfasserIn] Neels, P Boel, M Jorens, P Lagae, L

Format:	E-Artikel

Erschienen:	2013

Übergeordnetes Werk:	Enthalten in: Biologically active vallesamine, strychnan, and rhazinilam alkaloids from - Lim, Jun-Lee ELSEVIER, 2015, ejpn : official journal of the European Paediatric Neurology Society, Burlington, Mass
Übergeordnetes Werk:	volume:17 ; year:2013 ; pages:4

Links:	Volltext

DOI / URN:	10.1016/S1090-3798(13)70013-8

Katalog-ID:	ELV011782056

Internformat


LEADER	01000caa a22002652 4500
001	ELV011782056
003	DE-627
005	20230623092902.0
007	cr uuu---uuuuu
008	180602s2013 xx \|\|\|\|\|o 00\| \|\|und c
024	7		\|a 10.1016/S1090-3798(13)70013-8 \|2 doi
028	5	2	\|a GBVA2013018000011.pica
035			\|a (DE-627)ELV011782056
035			\|a (ELSEVIER)S1090-3798(13)70013-8
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
082	0		\|a 610
082	0	4	\|a 610 \|q DE-600
082	0	4	\|a 580 \|a 540 \|q VZ
084			\|a BIODIV \|q DE-30 \|2 fid
084			\|a 42.00 \|2 bkl
100	1		\|a Ceulemans, B \|e verfasserin \|4 aut
245	1	0	\|a O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up
264		1	\|c 2013
336			\|a nicht spezifiziert \|b zzz \|2 rdacontent
337			\|a nicht spezifiziert \|b z \|2 rdamedia
338			\|a nicht spezifiziert \|b zu \|2 rdacarrier
700	1		\|a Neels, P \|4 oth
700	1		\|a Boel, M \|4 oth
700	1		\|a Jorens, P \|4 oth
700	1		\|a Lagae, L \|4 oth
773	0	8	\|i Enthalten in \|n Harcourt \|a Lim, Jun-Lee ELSEVIER \|t Biologically active vallesamine, strychnan, and rhazinilam alkaloids from \|d 2015 \|d ejpn : official journal of the European Paediatric Neurology Society \|g Burlington, Mass \|w (DE-627)ELV001176439
773	1	8	\|g volume:17 \|g year:2013 \|g pages:4
856	4	0	\|u https://doi.org/10.1016/S1090-3798(13)70013-8 \|3 Volltext
912			\|a GBV_USEFLAG_U
912			\|a GBV_ELV
912			\|a SYSFLAG_U
912			\|a FID-BIODIV
912			\|a SSG-OLC-PHA
936	b	k	\|a 42.00 \|j Biologie: Allgemeines \|q VZ
951			\|a AR
952			\|d 17 \|j 2013 \|h 4 \|y 17.2013, S4-
953			\|2 045F \|a 610

Indexfelder

author_variant	b c bc
matchkey_str	ceulemansbneelspboelmjorensplagael:2013----:116scesuuefefuaiesdotetetnrvtydoet
hierarchy_sort_str	2013
bklnumber	42.00
publishDate	2013
allfields	10.1016/S1090-3798(13)70013-8 doi GBVA2013018000011.pica (DE-627)ELV011782056 (ELSEVIER)S1090-3798(13)70013-8 DE-627 ger DE-627 rakwb 610 610 DE-600 580 540 VZ BIODIV DE-30 fid 42.00 bkl Ceulemans, B verfasserin aut O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neels, P oth Boel, M oth Jorens, P oth Lagae, L oth Enthalten in Harcourt Lim, Jun-Lee ELSEVIER Biologically active vallesamine, strychnan, and rhazinilam alkaloids from 2015 ejpn : official journal of the European Paediatric Neurology Society Burlington, Mass (DE-627)ELV001176439 volume:17 year:2013 pages:4 https://doi.org/10.1016/S1090-3798(13)70013-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 42.00 Biologie: Allgemeines VZ AR 17 2013 4 17.2013, S4- 045F 610
spelling	10.1016/S1090-3798(13)70013-8 doi GBVA2013018000011.pica (DE-627)ELV011782056 (ELSEVIER)S1090-3798(13)70013-8 DE-627 ger DE-627 rakwb 610 610 DE-600 580 540 VZ BIODIV DE-30 fid 42.00 bkl Ceulemans, B verfasserin aut O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neels, P oth Boel, M oth Jorens, P oth Lagae, L oth Enthalten in Harcourt Lim, Jun-Lee ELSEVIER Biologically active vallesamine, strychnan, and rhazinilam alkaloids from 2015 ejpn : official journal of the European Paediatric Neurology Society Burlington, Mass (DE-627)ELV001176439 volume:17 year:2013 pages:4 https://doi.org/10.1016/S1090-3798(13)70013-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 42.00 Biologie: Allgemeines VZ AR 17 2013 4 17.2013, S4- 045F 610
allfields_unstemmed	10.1016/S1090-3798(13)70013-8 doi GBVA2013018000011.pica (DE-627)ELV011782056 (ELSEVIER)S1090-3798(13)70013-8 DE-627 ger DE-627 rakwb 610 610 DE-600 580 540 VZ BIODIV DE-30 fid 42.00 bkl Ceulemans, B verfasserin aut O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neels, P oth Boel, M oth Jorens, P oth Lagae, L oth Enthalten in Harcourt Lim, Jun-Lee ELSEVIER Biologically active vallesamine, strychnan, and rhazinilam alkaloids from 2015 ejpn : official journal of the European Paediatric Neurology Society Burlington, Mass (DE-627)ELV001176439 volume:17 year:2013 pages:4 https://doi.org/10.1016/S1090-3798(13)70013-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 42.00 Biologie: Allgemeines VZ AR 17 2013 4 17.2013, S4- 045F 610
allfieldsGer	10.1016/S1090-3798(13)70013-8 doi GBVA2013018000011.pica (DE-627)ELV011782056 (ELSEVIER)S1090-3798(13)70013-8 DE-627 ger DE-627 rakwb 610 610 DE-600 580 540 VZ BIODIV DE-30 fid 42.00 bkl Ceulemans, B verfasserin aut O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neels, P oth Boel, M oth Jorens, P oth Lagae, L oth Enthalten in Harcourt Lim, Jun-Lee ELSEVIER Biologically active vallesamine, strychnan, and rhazinilam alkaloids from 2015 ejpn : official journal of the European Paediatric Neurology Society Burlington, Mass (DE-627)ELV001176439 volume:17 year:2013 pages:4 https://doi.org/10.1016/S1090-3798(13)70013-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 42.00 Biologie: Allgemeines VZ AR 17 2013 4 17.2013, S4- 045F 610
allfieldsSound	10.1016/S1090-3798(13)70013-8 doi GBVA2013018000011.pica (DE-627)ELV011782056 (ELSEVIER)S1090-3798(13)70013-8 DE-627 ger DE-627 rakwb 610 610 DE-600 580 540 VZ BIODIV DE-30 fid 42.00 bkl Ceulemans, B verfasserin aut O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up 2013 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Neels, P oth Boel, M oth Jorens, P oth Lagae, L oth Enthalten in Harcourt Lim, Jun-Lee ELSEVIER Biologically active vallesamine, strychnan, and rhazinilam alkaloids from 2015 ejpn : official journal of the European Paediatric Neurology Society Burlington, Mass (DE-627)ELV001176439 volume:17 year:2013 pages:4 https://doi.org/10.1016/S1090-3798(13)70013-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 42.00 Biologie: Allgemeines VZ AR 17 2013 4 17.2013, S4- 045F 610
source	Enthalten in Biologically active vallesamine, strychnan, and rhazinilam alkaloids from Burlington, Mass volume:17 year:2013 pages:4
sourceStr	Enthalten in Biologically active vallesamine, strychnan, and rhazinilam alkaloids from Burlington, Mass volume:17 year:2013 pages:4
format_phy_str_mv	Article
bklname	Biologie: Allgemeines
institution	findex.gbv.de
dewey-raw	610
isfreeaccess_bool	false
container_title	Biologically active vallesamine, strychnan, and rhazinilam alkaloids from
authorswithroles_txt_mv	Ceulemans, B @@aut@@ Neels, P @@oth@@ Boel, M @@oth@@ Jorens, P @@oth@@ Lagae, L @@oth@@
publishDateDaySort_date	2013-01-01T00:00:00Z
hierarchy_top_id	ELV001176439
dewey-sort	3610
id	ELV011782056
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV011782056</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623092902.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx \|\|\|\|\|o 00\| \|\|und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1090-3798(13)70013-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013018000011.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV011782056</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1090-3798(13)70013-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">580</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ceulemans, B</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neels, P</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boel, M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jorens, P</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lagae, L</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Lim, Jun-Lee ELSEVIER</subfield><subfield code="t">Biologically active vallesamine, strychnan, and rhazinilam alkaloids from</subfield><subfield code="d">2015</subfield><subfield code="d">ejpn : official journal of the European Paediatric Neurology Society</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV001176439</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:17</subfield><subfield code="g">year:2013</subfield><subfield code="g">pages:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1090-3798(13)70013-8</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.00</subfield><subfield code="j">Biologie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">17</subfield><subfield code="j">2013</subfield><subfield code="h">4</subfield><subfield code="y">17.2013, S4-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
author	Ceulemans, B
spellingShingle	Ceulemans, B ddc 610 ddc 580 fid BIODIV bkl 42.00 O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up
authorStr	Ceulemans, B
ppnlink_with_tag_str_mv	@@773@@(DE-627)ELV001176439
format	electronic Article
dewey-ones	610 - Medicine & health 580 - Plants (Botany) 540 - Chemistry & allied sciences
delete_txt_mv	keep
author_role	aut
collection	elsevier
remote_str	true
illustrated	Not Illustrated
topic_title	610 610 DE-600 580 540 VZ BIODIV DE-30 fid 42.00 bkl O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up
topic	ddc 610 ddc 580 fid BIODIV bkl 42.00
topic_unstemmed	ddc 610 ddc 580 fid BIODIV bkl 42.00
topic_browse	ddc 610 ddc 580 fid BIODIV bkl 42.00
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	zu
author2_variant	p n pn m b mb p j pj l l ll
hierarchy_parent_title	Biologically active vallesamine, strychnan, and rhazinilam alkaloids from
hierarchy_parent_id	ELV001176439
dewey-tens	610 - Medicine & health 580 - Plants (Botany) 540 - Chemistry
hierarchy_top_title	Biologically active vallesamine, strychnan, and rhazinilam alkaloids from
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)ELV001176439
title	O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up
ctrlnum	(DE-627)ELV011782056 (ELSEVIER)S1090-3798(13)70013-8
title_full	O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up
author_sort	Ceulemans, B
journal	Biologically active vallesamine, strychnan, and rhazinilam alkaloids from
journalStr	Biologically active vallesamine, strychnan, and rhazinilam alkaloids from
isOA_bool	false
dewey-hundreds	600 - Technology 500 - Science
recordtype	marc
publishDateSort	2013
contenttype_str_mv	zzz
container_start_page	4
author_browse	Ceulemans, B
container_volume	17
class	610 610 DE-600 580 540 VZ BIODIV DE-30 fid 42.00 bkl
format_se	Elektronische Aufsätze
author-letter	Ceulemans, B
doi_str_mv	10.1016/S1090-3798(13)70013-8
dewey-full	610 580 540
title_sort	o11 – 1866 successful use of fenfluramine as add-on treatment in dravet syndrome: a two year prospective follow up
title_auth	O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up
collection_details	GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA
title_short	O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up
url	https://doi.org/10.1016/S1090-3798(13)70013-8
remote_bool	true
author2	Neels, P Boel, M Jorens, P Lagae, L
author2Str	Neels, P Boel, M Jorens, P Lagae, L
ppnlink	ELV001176439
mediatype_str_mv	z
isOA_txt	false
hochschulschrift_bool	false
author2_role	oth oth oth oth
doi_str	10.1016/S1090-3798(13)70013-8
up_date	2024-07-06T20:49:00.783Z
_version_	1803864182131523584
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV011782056</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623092902.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx \|\|\|\|\|o 00\| \|\|und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1090-3798(13)70013-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013018000011.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV011782056</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1090-3798(13)70013-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">580</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ceulemans, B</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neels, P</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boel, M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jorens, P</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lagae, L</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Lim, Jun-Lee ELSEVIER</subfield><subfield code="t">Biologically active vallesamine, strychnan, and rhazinilam alkaloids from</subfield><subfield code="d">2015</subfield><subfield code="d">ejpn : official journal of the European Paediatric Neurology Society</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV001176439</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:17</subfield><subfield code="g">year:2013</subfield><subfield code="g">pages:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1090-3798(13)70013-8</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.00</subfield><subfield code="j">Biologie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">17</subfield><subfield code="j">2013</subfield><subfield code="h">4</subfield><subfield code="y">17.2013, S4-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
score	7.4010277

Nicht das Richtige dabei?

Schreiben Sie uns!

O11 – 1866 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: a two year prospective follow up

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?